Tower Research Capital (TRC)’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Buy |
5,244
+3,326
| +173% | +$21.6K | ﹤0.01% | 3307 |
|
|
2025
Q1 | $15.2K | Sell |
1,918
-8,739
| -82% | -$69.3K | ﹤0.01% | 3232 |
|
|
2024
Q4 | $135K | Buy |
10,657
+9,603
| +911% | +$122K | ﹤0.01% | 1978 |
|
|
2024
Q3 | $14.7K | Sell |
1,054
-22,595
| -96% | -$315K | ﹤0.01% | 3446 |
|
|
2024
Q2 | $326K | Buy |
23,649
+21,949
| +1,291% | +$302K | 0.01% | 1692 |
|
|
2024
Q1 | $28.1K | Sell |
1,700
-205
| -11% | -$3.39K | ﹤0.01% | 2706 |
|
|
2023
Q4 | $27.8K | Buy |
1,905
+212
| +13% | +$3.1K | ﹤0.01% | 3462 |
|
|
2023
Q3 | $20.8K | Sell |
1,693
-1,478
| -47% | -$18.1K | ﹤0.01% | 3337 |
|
|
2023
Q2 | $37.9K | Sell |
3,171
-3,615
| -53% | -$43.2K | ﹤0.01% | 2796 |
|
|
2023
Q1 | $91K | Buy |
6,786
+4,350
| +179% | +$58.3K | ﹤0.01% | 1951 |
|
|
2022
Q4 | $53K | Buy |
2,436
+250
| +11% | +$5.44K | ﹤0.01% | 2299 |
|
|
2022
Q3 | $44K | Sell |
2,186
-1,564
| -42% | -$31.5K | ﹤0.01% | 3275 |
|
|
2022
Q2 | $67K | Buy |
3,750
+1,940
| +107% | +$34.7K | ﹤0.01% | 2616 |
|
|
2022
Q1 | $18K | Buy |
1,810
+763
| +73% | +$7.59K | ﹤0.01% | 3618 |
|
|
2021
Q4 | $17K | Buy |
1,047
+513
| +96% | +$8.33K | ﹤0.01% | 3842 |
|
|
2021
Q3 | $12K | Buy |
534
+524
| +5,240% | +$11.8K | ﹤0.01% | 4139 |
|
|
2021
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 5526 |
|